Literature DB >> 3118111

S-phase lymphocytes in chronic lymphocytic leukemia (CLL) in relation to immunoglobulin isotypes on the leukemic clone and to disease activity.

E Kimby1, H Mellstedt, B Nilsson, B Tribukait, M Björkholm, G Holm.   

Abstract

The fraction of blood S-phase (S+) lymphocytes from 41 patients with chronic lymphocytic leukemia of B cell type was determined by flow cytometry. The patients were grouped according to the smig isotype pattern of the leukemic cells. Patients with IgM as the predominant smig had higher numbers of S+ lymphocytes than patients with a leukemic clone co-expressing IgM and IgD (p less than 0.001). High relative as well as total numbers of S+ lymphocytes were associated with short therapy-free and overall survival. T cell proliferation was low although significantly higher in active than in indolent disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3118111

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  3 in total

1.  Expression of interleukin-1 alpha, interleukin-1 beta and interleukin-6 in chronic B lymphocytic leukaemia (B-CLL) cells from patients at different stages of disease progression.

Authors:  M Aguilar-Santelises; R Magnusson; S B Svenson; A Loftenius; B Andersson; H Mellstedt; M Jondal
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

2.  Activities of DNA-PK and Ku86, but not Ku70, may predict sensitivity to cisplatin in human gliomas.

Authors:  Cui-Jie Shao; Jun Fu; Hong-Liu Shi; Yong-Gao Mu; Zhong-Ping Chen
Journal:  J Neurooncol       Date:  2008-04-16       Impact factor: 4.130

3.  Presence of clonal T cell populations in chronic B lymphocytic leukemia and smoldering myeloma.

Authors:  T Wen; H Mellstedt; M Jondal
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.